Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Pratley RE, Aroda VR, Lingvay I, et al.
The Lancet Diabetes & Endocrinology. 2018;6(4):275-86
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Pratley RE, Aroda VR, Lingvay I, et al.
The Lancet Diabetes & Endocrinology. 2018;6(4):275-86
Leggi
The Lancet Diabetes & Endocrinology. April 2018; 6 (4): 259.
Leggi
Hales CM, Fryar CD, Carroll MD, et al.
JAMA. Published online March 23, 2018.
Leggi
Yu D, Graffy J, Holman D, et al.
Diabetic Medicine. Pub. online March 25, 2018.
Leggi
Arredondo A
The Lancet Diabetes & Endocrinology. Pub. online March 19, 2018.
Leggi
Herrington WG, Alegre-Díaz J, Wade R, et al.
The Lancet Diabetes & Endocrinology. Pub. online March 19, 2018.
Leggi
Chapman AR, Shah ASV, Lee KK, et al.
Circulation. 2018;137:1236-45
Leggi
Safai N, Carstensen B, Vestergaard H, Ridderstråle M
BMJ Open 2018;8:e019214
Leggi
Brown AF, Liang L-J, Vassar SD, et al.
Annals of Internal Medicine. Pub. online 20 March 2018.
Leggi
Mensah GA
Annals of Internal Medicine. Pub. online 20 March 2018.
Leggi